Article
Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.
Journal of inherited metabolic disease - 1 Jan 2016
Huemer Martina, Mulder-Bleile Regina, Burda Patricie, Froese D Sean, Suormala Terttu, Zeev Bruria Ben, Chinnery Patrick F, Dionisi-Vici Carlo, Dobbelaere Dries, Gökcay Gülden, Demirkol Mübeccel, Häberle Johannes, Lossos Alexander, Mengel Eugen, Morris Andrew A, Niezen-Koning Klary E, Plecko Barbara, Parini Rossella, Rokicki Dariusz, Schiff Manuel, Schimmel Mareike, Sewell Adrian C, Sperl Wolfgang, Spiekerkoetter Ute, Steinmann Beat, Taddeucci Grazia, Trejo-Gabriel-Galán Jose M, Trefz Friedrich, Tsuji Megumi, Vilaseca María Antònia, von Kleist-Retzow Jürgen-Christoph, Walker Valerie, Zeman Jiri, Baumgartner Matthias R, Fowler Brian
Abstract excerpt
BACKGROUND: Severe methylenetetrahydrofolate reductase (MTHFR) deficiency is a rare inborn defect disturbing the remethylation of homocysteine to methionine (<200 reported cases). This retrospective study evaluates clinical, biochemical genetic and in vitro enzymatic data in a cohort of 33 patients. METHODS: Clinical, biochemical and treatment data was obtained from physicians by using a questionnaire. MTHFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
